Apr. 14 at 5:11 PM
$RDIB 🤫NASDAQ:МYNZ — Not Just Another Biotech. It’s Moving.
While most chase noise, Маіnz Віоmеd keeps building around mRNA, diagnostics, and early cancer detection — the exact space biotech money’s targeting.
📈 Trading above
$3.37 now — volume steady, float tight, no PR yet.
Still underexposed. Still early. But that window’s narrowing.
🧪 Microfloat. U.S.-based. Fits every biotech funding screen out there.
This isn’t just a sleeper — it’s a setup.
The chart’s tightening. The story’s strong.
One headline, and it’s gone.
📊 I’m not watching from the sidelines — I’m already positioned.
Let’s see how this plays out. Could move fast.
DYOR. But maybe do it before this wakes up for real.
